BRIEF BIOSKETCH

Andrey Bayanov, M.D., Ph.D.

SUMMARY OF WORK EXPERIENCE

2012 – present Principal Consultant in pipeline/portfolio analysis, strategic planning and R&D for bio/pharma companies and venture funds at Health Recode LLC, Spain
2010-12 Medical Affairs Manager at R-Pharm Group, Moscow, Russia
2007-10 Consultant at GfK Healthcare and Ipsos CEE, Moscow, Russia
2003-06 Adviser and Key Expert for EC, WB and USAID’s health technology development projects in Russia and Ukraine at HLSP Consulting Spain, IREX Russia, and WYG International UK
1996-03 Registrar in Psychiatry, then Consultant psychiatrist; pioneered the personalized medicine approach at mental health clinics and general hospitals of Novosibirsk, Russia

EDUCATION

1994-97 PhD in Pharmacology; Postgraduate Research Fellowship, Tomsk Research Institute of Pharmacology, Russian Academy of Medical Sciences
1988-94 MD, Diploma of Pediatrician; Novosibirsk State Medical University (NSMU), Russia (nostrified as Family Medicine Doctor by the Ministry of Education and Science of Spain, 2005)

PROFESSIONAL TRAINING

2011-22 Online seminars in Precision Medicine, Genetics and Pharmacogenomics, Roche Institute, Spain
2013 eLearning course in Research Commercialization, National Council of Entrepreneurial Tech Transfer, USA
2013 eLearning course in Drug Discovery, Development & Commercialization, UCSD, Skaggs School of Pharmacy and Pharmaceutical Sciences, USA
2013 eLearning course in Genomics and Biotechnology, University of Maryland, USA
2013, 2003 eLearning course, and Internship in Health Technology Assessment, University of Sheffield, UK, and HLSP Consulting/ Europe, Barcelona, Spain
2003 CME courses on innovative treatments for tuberculosis, HIV, and mental disorders, UITB and WPA, Barcelona, Spain
1997-00 Residency and advanced trainings in Psychiatry and Behavioral Psychology, NSMU and Russian Medical Academy for Postgraduate Education, Moscow

KEY QUALIFICATIONS

New Product Portfolio Development:

  • Independent thought and judgment to evaluate strategically new bio/pharma science technology developments
  • In-depth understanding of the drug development phases and master skills in drug lifecycle strategic planning
  • Excellent “first filter” capacities for BD incoming opportunities
  • Good skills in in/out-licensing transactions for R&D technologies, products, and marketed brands
  • Extensive experience in international/national IP information search and evaluation
  • Ability to identify prospective partners, build relationships, and communicate across a variety of audiences.

Pharma Market Intelligence & Analysis:

  • Expert skills in market intelligence and comprehensive coverage analysis in any TA to identify best investable niches and marketing strategies
  • Hands-on experience in conducting qualitative marketing researches
  • Expert specialist in translating of unmet medical needs and scientific insights into functional applications

Personalized Medicine & Clinical Project Development:

  • Hands-on experience in scientific research with the ability to review and collate data from the scientific sources
  • Good knowledge of GCP, EBM, translational research, precision medicine, HTA, and their application in the drug development phases
  • Master skills in integrating of pharmacogenetics and functional genomics data into personalized medicine applications
  • In-depth understanding of disease biomarkers and therapeutic targets search, analysis and validation strategies
  • Expert skills in preclinical and clinical pharmacological expertise (PK/PD, DMPK and ADME analysis, drug efficacy, safety, pharmacoepidemiology)

Other relevant skills:

  • Good knowledge of health policies and technology assessment principles across Europe
  • Excellent capacities in gathering, compiling and summarizing a complex set of scientific facts
  • Good skills to manage multiple projects, work independently, and lead a team of professionals
  • Fluent trilingual Internet surfing of biomedicine knowledge bases, phenome/genome repositories and datasets
  • Writing analytical reviews, reports and original scientific issues in English, Spanish and Russian languages

Top

Обсуждение закрыто.